September 2022 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

Note: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2023 Concepts

FY 2024 Concepts

Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC)

For the published request for applications, check the August 9, 2022 Guide announcement, Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01, Clinical Trial Not Allowed).

National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC)

For the published request for applications, check the August 9, 2022 Guide announcement, National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01, Clinical Trial Not Allowed).

Transplantation Statistical and Clinical Coordinating Center (T-SCCC)

For the published request for applications, check the August 9, 2022 Guide announcement, Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01, Clinical Trial Not Allowed).

Consortium for Food Allergy Research, Clinical Research Centers

For the published request for applications, check the February 7, 2023 Guide announcement, Consortium for Food Allergy Research—Clinical Research Center (U01, Clinical Trial Required).

Consortium for Food Allergy Research, CoFAR Leadership Center

For the published request for applications, check the February 7, 2023 Guide announcement, Consortium for Food Allergy Research—Leadership Center (UM1, Clinical Trial Required).

Vaccine Adjuvant Discovery Program

For the published broad agency announcement, check the December 20, 2022 solicitation, Vaccine Adjuvant Discovery Program.

Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices

For the published broad agency announcement, check the November 28, 2022 solicitation, Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices.

Sex Differences in Radiation/Nuclear Research: Models, Underlying Pathways, Biomarkers of Injury, and Medical Countermeasure Responses

For the published request for applications, check the May 5, 2023 Guide announcement, Sex Differences in Radiation Research: Models, Underlying Pathways, Biomarkers of Injury, and Medical Countermeasure Responses (U01, Clinical Trial Not Allowed)

 

Content last reviewed on